What is Evommune 's debt repayments?

Evommune (EVMN) reported debt repayments of $149.14K in Q1 2026.

What does debt repayments mean?

Reflects the total cash outflows used to satisfy principal obligations on outstanding debt instruments. Monitoring this helps investors understand the company's commitment to deleveraging and its ongoing debt service requirements.

Evommune EVMN Debt Repayments

Debt Repayments at other companies

BlackbaudBLKB

$74.97M-12.3%

ValvolineVVV

$22.8M+280%

Columbia Financial, Inc.CLBK

$0—

Lexicon PharmaceuticalsLXRX

$5M—

Albany International Inc.AIN

$42M+1,297%

Evommune EVMN

$149.14K+8,751%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's debt repayments?: Evommune (EVMN) reported debt repayments of $149.14K in Q1 2026.
What does debt repayments mean?: Reflects the total cash outflows used to satisfy principal obligations on outstanding debt instruments. Monitoring this helps investors understand the company's commitment to deleveraging and its ongoing debt service requirements.